- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 23, 2026 | 58.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 58.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 58.36M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $23.11M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $21.39M |
| Capex | Q1 2026 · Mar 31, 2026 | $15.96M |
| Capex | Q1 2026 · Mar 31, 2025 | $10.58M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $170.66M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $147.99M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $98.41M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $120.53M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $715.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $695.74M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.41B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.58B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.13B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.28B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.61 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.42 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.62 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.44 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $57.09M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $63.79M |
| Net Income | Q1 2026 · Mar 31, 2026 | $35.79M |
| Net Income | Q1 2026 · Mar 31, 2025 | $24.79M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $77.44M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $62.62M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $586.46M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $550.13M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $633.27M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $626.23M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.22B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.18B |